Delivra Health Brands CEO Gord Davey joined Steve Darling from Proactive to share news shared updates with Proactive regarding the company’s financial and operating results for the fiscal year ending June 30, 2024. Delivra Health, known for its Dream Water® and LivRelief™ brands, which address health concerns like sleeplessness, chronic pain, and anxiety, continues to show financial growth and stability. For the second consecutive year, the company achieved positive Adjusted EBITDA and positive cash flow. Total net revenue rose by 26%, driven by strong sales in the U.S. and Canada due to increased customer orders and consumer demand. The company’s gross profit margin increased to 52%, with a gross profit margin improvement of 49%. Additionally, Adjusted EBITDA saw a 68% year-over-year increase, credited to better customer mix, enhanced profit margins, and streamlined administrative functions. Delivra Health remains committed to further growth as it continues to strengthen its market presence. #proactiveinveestors #delivrahealthbrandsinc #tsxv #dhb #otcqb #dhbuf #DreamWater #GlobalExpansion #UAE #MiddleEastMarket #SleepAid #HealthAndWellness #PharmacyProducts #RegulatoryCompliance #DubaiWarehouse #ProductLaunch #MarketGrowth #InternationalBusiness #HealthSupplements #LabelTranslation #Pharmaceuticals #ConsumerProducts #GlobalStrategy #HealthBrands #ExpansionNews #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews